News
-
New product launch: APOHEALTH Allergy & Hayfever Nasal Spray 120 dose
Wednesday | Sep 3 2025APOHEALTH Allergy & Hayfever Nasal Spray 120 dose is an affordable alternative to Dymista Allergy Nasal Spray, which is used for the treatment of moderate to severe allergic rhinitis (hayfever) symptoms such as sneezing, runny, itchy, and/or blocked nose.
-
Mag-Sup powder – a better way to absorb magnesium
Wednesday | Sep 3 2025MAG-SUP powder is a high absorption magnesium supplement for use in magnesium deficiencies.
-
Code of ethics consultation opens
Tuesday | Sep 2 2025THE Code of Ethics for Pharmacists is up for renewal, with the Pharmaceutical Society of Australia (PSA) seeking feedback from pharmacists and health sector stakeholders as it begins the consultation phase of reviewing the code.
-
Antimicrobial use rises
Tuesday | Sep 2 2025THE Australian Commission on Safety and Quality in Health Care has released its 2024 data for antimicrobial use in the community, describing the findings as "encouraging".
-
Educating patients on pain
Tuesday | Sep 2 2025WITH new regulations around the scheduling of paracetamol pack sizes and the down-scheduling of COX-2 inhibitors coming in this year, consumers are faced with a growing - and potentially confusing - range of pain relief options.
-
Maximise your day
Tuesday | Sep 2 2025NEW Maxofen from Nova Pharmaceuticals combines paracetamol and ibuprofen for double-action relief from acute pain and fever.
-
AI in healthcare
Tuesday | Sep 2 2025THE Australasian Institute of Digital Health's premier AI data-driven healthcare event, AI.Care 2025, is taking place in Brisbane from 24-25 Nov.
-
Pneumococcal vax update
Tuesday | Sep 2 2025THE new Prevenar 20 pneumococcal vaccine (20vPCV) has now replaced the Prevenar 13 and Pneumovax 23 (23vPPV) on the childhood immunisation schedule, and will protect against 20 prominent types of the disease.
-
Sansom Lecture rego opens
Tuesday | Sep 2 2025THE Australian Pharmacy Council (APC) has announced that registrations for the 2025 Sansom Lecture are now open.
-
No CVD benefit from daily aspirin
Tuesday | Sep 2 2025HEALTHY older adults who take a low-dose of aspirin daily may experience a higher risk of a major haemorrhage without any overall cardiovascular benefit, according to research led by Monash University.
